
UB668
IndicationsPulmonary fibrosis
ClinicalCN - Preclinical
TherapeuticsRespiratory
ModalitiesNucleic Acid Therapeutics
Exclusive Summary
- Poised to become a first-in-class siRNA therapeutic for the treatment of idiopathic pulmonary fibrosis (IPF)
我们能如何帮助您?
获取最新活动与法规动态洞察
直接发送到您的邮箱
在此获取行业洞察与 Unibest 动态
联系我们 →